ABOUT US

Carnegie Medtech Services (CMS) is an M.H. Carnegie & Co. portfolio company. CMS supports early and late-stage medical technology companies focused on commercialisation within the Asia Pacific region.. As a fully integrated Asia Pacific service provider CMS is committed to being a trusted extension of each client’s team. Partnering with CMS allows companies to deliver full strategic focus on the Asia Pacific region with a minimum distraction of internal resources. Entering the Asia Pacific market requires long-term commitment and capital. As a loyal partner, CMS will share the risk with regard to business growth in this region.

FIND OUT MORE

CLIENT PORTFOLIO

Renew Medical
Renew Medical is an Australian-based medical device company that has researched, developed and clinically tested the Renew Insert which helps prevent Accidental Bowel Leakage (ABL). The resulting one-time use product is unique in its combination of safety, effectiveness, comfort, ease of use and is a clean and hygienic...
Read more
Simplify Medical
Simplify’s technology is built upon clinically successful designs that have been implanted in over 4,000 patients worldwide with over five years of follow up clinical data. Simplify’s disc is designed to preserve motion in patients suffering from SCDD. Simplify eliminates the need for CT/Myelogram and CT imagin...
Read more
Serene Medical
Serene was established in late 2010 when their IP was licensed out of Merz. The Company is currently based in Sydney, Australia and the San Francisco Bay Area, California. In August 2014 M. H. Carnegie & Co. together with Blue Sky Ventures co-led a US$3.0mn financing to provide capital for the business to ru...
Read more

News

02 Dec

Cardiac Dimensions announces IDE approval from the FDA to conduct a U.S. pivotal study

Blog
KIRKLAND, Wash., Dec. 1, 2016 /PRNewswire/ -- Cardiac Dimensions, the leader in minimally invasive repair therapies for functional mitral regurgitation (FMR), today announced U.S. Food and Drug Administration (FDA) approval of its Investigational De...
Read more
01 Feb

Our government’s best policy which supports Australian innovation

Blog
The Australian Federal Government provides around $2bn a year of cash and/or tax offset incentives to Australian-based companies that are engaged in research and development (R&D) through the R&D tax incentive program. M. H. Carnegie (Carnegie) believe...
Read more
01 Feb

Serene Medical announces completed enrolment of the first clinical trial to show duration ...

Blog
SAN RAMON, Calif., Jan. 19, 2016 /PRNewswire/ -- Serene Medical Pty. Ltd., a medical device pioneer in RF technology, has recently completed enrollment of its prospective multi-center trial evaluating the effectiveness of the Serene RF System. The Serene clin...
Read more

EXPRESSION OF INTEREST